GLP‐1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications

Peter Ueda
Journal of Internal Medicine · Wiley · 2026-11-06 · DOI: 10.1111/joim.70170

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles